NCT05986942View on ClinicalTrials.gov

Evaluation of the Postoperative Agitation Prevention and Analgesic Efficacy of Perioperative Dexmedetomidine Infusion in a Pediatric Patient Group to Undergo Tonsillectomy and Adenoidectomy

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

October 9, 2023

Primary Completion Date

November 7, 2023

Study Completion Date

November 7, 2023

Conditions
AnxietyPostoperative PainBleeding
Interventions
DRUG

Fentanyl

In Group dex, dexmedetomidine infusion will be administered to the patient during the operation. Fentanyl bolus dose will be administered during anesthesia induction in group Fen.

DRUG

Dexmedetomidine

In Group dex, dexmedetomidine infusion will be administered to the patient during the operation. Fentanyl bolus dose will be administered during anesthesia induction in group Fen.

Trial Locations (1)

Unknown

Istanbul Medipol University, Istanbul

All Listed Sponsors
lead

Burak Omur

OTHER

NCT05986942 - Evaluation of the Postoperative Agitation Prevention and Analgesic Efficacy of Perioperative Dexmedetomidine Infusion in a Pediatric Patient Group to Undergo Tonsillectomy and Adenoidectomy | Biotech Hunter | Biotech Hunter